Charles Ryhee
Stock Analyst at TD Cowen
(2.48)
# 2,490
Out of 5,090 analysts
17
Total ratings
60%
Success rate
10.88%
Average return
Main Sectors:
Stocks Rated by Charles Ryhee
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| CVS CVS Health | Maintains: Buy | $73 → $80 | $75.63 | +5.78% | 5 | Nov 25, 2024 | |
| MCK McKesson | Maintains: Buy | $563 → $652 | $808.62 | -19.37% | 4 | May 8, 2024 | |
| CVX Chevron | Maintains: Outperform | $185 → $170 | $150.00 | +13.33% | 3 | Feb 24, 2023 | |
| EVH Evolent Health | Maintains: Outperform | $57 → $59 | $3.94 | +1,397.46% | 2 | Jan 30, 2023 | |
| CAH Cardinal Health | Maintains: Market Perform | $59 → $72 | $198.83 | -63.79% | 1 | Aug 16, 2022 | |
| TDOC Teladoc Health | Maintains: Outperform | $240 → $188 | $7.59 | +2,376.94% | 1 | Aug 9, 2021 | |
| OSCR Oscar Health | Initiates: Market Perform | $29 | $16.77 | +72.93% | 1 | Mar 29, 2021 |
CVS Health
Nov 25, 2024
Maintains: Buy
Price Target: $73 → $80
Current: $75.63
Upside: +5.78%
McKesson
May 8, 2024
Maintains: Buy
Price Target: $563 → $652
Current: $808.62
Upside: -19.37%
Chevron
Feb 24, 2023
Maintains: Outperform
Price Target: $185 → $170
Current: $150.00
Upside: +13.33%
Evolent Health
Jan 30, 2023
Maintains: Outperform
Price Target: $57 → $59
Current: $3.94
Upside: +1,397.46%
Cardinal Health
Aug 16, 2022
Maintains: Market Perform
Price Target: $59 → $72
Current: $198.83
Upside: -63.79%
Teladoc Health
Aug 9, 2021
Maintains: Outperform
Price Target: $240 → $188
Current: $7.59
Upside: +2,376.94%
Oscar Health
Mar 29, 2021
Initiates: Market Perform
Price Target: $29
Current: $16.77
Upside: +72.93%